Institutions / Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC

CIK 1844645 · Institution · as of Dec 31, 2025
Portfolio value
$258.66M
Positions
12
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Vaxcyte, Inc.—$63.32M1,372,42524.5%
Oculis Holding AG—$45.70M2,288,65817.7%
Arcutis Biotherapeutics, Inc.—$39.69M1,366,62415.3%
Evommune, Inc.EVMNCommon Stock$32.99M1,926,94312.8%
Zenas BioPharma, Inc.ZBIOCommon Stock$21.50M591,9918.3%
Trevi Therapeutics, Inc.—$15.73M1,256,7826.1%
Immunome Inc.—$15.73M732,5126.1%
Maplight Therapeutics IncMPLTCommon Stock$10.74M611,4474.2%
BioAge Labs, Inc.BIOACommon Stock$8.64M653,3743.3%
Recursion Pharmaceuticals, Inc.—$2.44M595,5180.9%
Rallybio Corp—$1.65M2,404,6440.6%
Bolt Biotherapeutics, Inc.BOLTCommon Stock$517.1K94,5730.2%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.